Virta Health, a startup to help people with diabetes receives $37M What other E-health companies received investment in March?

, ,
Integral service around a transaction
BY : Diego GutiérrezMarch Wed, 2017
Remote patient treatment, e-health data processing, Saas platform that helps doctors plan their schedule... e-health companies are receiving investment.
Some e-health companies that have received investment in March 2017

Virta Health, a startup to help people with diabetes receives $37M What other E-health companies received investment in March?

In this month of March, we have detected several young companies, less than 4 years old, which have already gained the support of investors.

Virta gets €37M - alternative treatment for diabetes.

Virta is a Sillicom Valley company, founded in 2014, which has just received its first round, and has done so for an amount of $37M. Virta is a platform for monitoring the carbohydrates we eat. It is intended for people who suffer from type II diabetes and have to constantly monitor their blood sugar with the prick of a needle and diabetic pills.

The company has raised €37M from VCs Venrock, Allen & Company, Obvious Ventures, Redmile Group and PayPal and Affirm. The goal of the round is to study new treatment options for diabetes II that could reverse the disorder.

In Spain there are also several companies that have developed solutions for the treatment of diabetes that have received investment. Catalan biopharmaceutical company Genmedica Therapeutics received a €1M round in 2014 for the development of a drug for the treatment of diabetes II and Social Diabetes has raised two smaller seed rounds.

CellAegis receives a round of $9M

CellAegis Devices (Toronto, Canada) has patented and developed a non-invasive, self-invasive device that provides Remote Ischaemic Isolation Therapy (RIC) to patients with acute and chronic cardiovascular disease.

The company has just closed a $$9.5M round to support a clinical trial in the US. The autoRIC device is approved in Canada and Europe, where it is being used in multiple large investigator-sponsored trials to evaluate its efficacy in reducing clinical events after a heart attack.

Other posts that may interest you

2016, a good year for the e-health sector in Spain?

ClinicPoint welcomes Ona Capital into its shareholding structure


If you are looking for investors, you want to buy or selling a companyplease contact us. Abra-Invest has a team of experts in each area at your disposal. Call +34 946424142 or fill in the contact form.

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?